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Background: Although use of standardized and scientifically sound outcome measures is highly encouraged in
clinical practice and research, there is still no clear recommendation on which tools should be preferred for upper
extremity assessment after stroke. As the aims, objectives and methodology of the existing reviews of the upper
extremity outcome measures can vary, there is a need to bring together the evidence from existing multiple
reviews. The purpose of this review was to provide an overview of evidence of the psychometric properties and
clinical utility of upper extremity outcome measures for use in stroke, by systematically evaluating and summarizing
findings from systematic reviews.
Methods: A comprehensive systematic search was performed including systematic reviews from 2004 to February
2014. A methodological quality appraisal of the reviews was performed using the AMSTAR-tool.
Results: From 13 included systematic reviews, 53 measures were identified of which 13 met the standardized
criteria set for the psychometric properties. The strongest level of measurement quality and clinical utility was
demonstrated for Fugl-Meyer Assessment, Action Research Arm Test, Box and Block Test, Chedoke Arm and Hand
Activity Inventory, Wolf Motor Function Test and ABILHAND.
Conclusions: This overview of systematic reviews provides a comprehensive systematic synthesis of evidence on
which outcome measures demonstrate a high level of measurement quality and clinical utility and which can be
considered as most suitable for upper extremity assessment after stroke. This overview can provide a valuable
resource to assist clinicians, researchers and policy makers in selection of appropriate outcome measures.
Keywords: Upper limb, Psychometrics, Rehabilitation, Outcome assessment (Health Care) outcome measures,
ReviewBackground
Stroke is a major cause of long-term disability worldwide
[1]. Motor impairments of the upper extremity are com-
mon and affect approximately 50-70% of patients in the
acute [2-4] and 40% in the chronic phase [5,6]. A per-
son’s ability to perform everyday tasks, to participate in
the society and the quality of life can be significantly
compromised after stroke [7].
Evaluation of the effectiveness of rehabilitation inter-
ventions after stroke is highly prioritized and encouraged
in stroke guidelines and policies. Despite consensus
among nationally published guidelines recommending* Correspondence: margit.alt-murphy@neuro.gu.se
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unless otherwise stated.the use of valid and reliable assessment tools, further
direction does not extend to which outcome measures
(OM) should be selected for particular evaluative needs
[8-11]. However more recently, two published physio-
therapy guidelines, the KNGF Clinical Practice Guideline
for physical therapy in patients with stroke [12] and the
Neurology section of the American Physical Therapy As-
sociation (StrokeEdge task force) [13] have provided
more specific recommendations. This suggests the avail-
ability of appropriate evidence for extended evaluation
and synthesis. Indeed, during the last decade, numerous
studies focusing on upper extremity OM have been pub-
lished, many highlighting the need of standardized defi-
nitions and higher consensus and guidance in OM
selection [14-16]. A more uniform reporting of OM in
stroke studies would allow comparison across studiestral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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dence synthesis. One example on improving standar-
dization of outcomes across several research areas is the
COMET (Core Outcome Measures in Effectiveness Tri-
als) initiative, which aims to improve development and
application of agreed standardized sets of outcomes, the
“core outcome sets” [17]. This initiative has recently
launched a database currently containing more than 500
references, but only a few of these target the stroke
population and upper extremity function is not yet cov-
ered [18,19]. The OM assessing the arm and hand func-
tion are, however, often included in studies and have
shown to be the second largest category of OM used in
randomized clinical trials after activities of daily living
measures [20].
The aims and objectives for systematic reviews of
upper extremity OM can vary. For example, a review
can only include OM to evaluate a specific type of inter-
vention (e.g. robot-assisted trials) [14,21] or only identify
OM reflecting real life function [22]. The majority of the
reviews evaluate the psychometric properties and clinical
utility of OM. Others focus on the process of OM selec-
tion involving participation by clinicians, management
and policy makers, and researchers [21,23]. In addition,
differences can exist between reviews regarding study in-
clusion, appraisal process and methodology. These vari-
ables make it more difficult for clinicians, researchers and
decision makers to determine which measures should be
selected to evaluate outcome, to facilitate clinical decision
making or to make a valid long-term prognosis.
As more systematic reviews are published, the poten-
tial to systematically compare integrate and synthesize
the findings increases. Recently, this kind of evidence
synthesis on reviews, known as overviews of systematic
reviews, has become more common [24-27]. An over-
view on reviews requires similar search strategy and
quality assessment as systematic reviews of primary lit-
erature, but relies on the findings reported by the re-
viewers rather than appraising the primary sources. This
approach allows synthesis of the evidence, where com-
parison and contrasting of the findings from single re-
views becomes possible and the identification of existing
gaps or trends in the literature more visible. Overviews
of systematic reviews can serve as an important source
of information for focused communication in the identi-
fication of OM that could be included into the clinical
practice stroke guidelines.
Currently, the European Network on Robotics for Neu-
rorehabilitation, funded by the European Co-operation in
science and technology (COST) action is developing
guidelines and evidence-based recommendations for
upper extremity assessment in neurological conditions.
This overview will be part of these guidelines focusing on
available evidence for upper extremity outcome measuresthat are recommended for use in clinical practice and re-
search. As part of the COST Action, we sought to estab-
lish the general state of knowledge in the area through a
structured overview of systematic reviews. The aim of this
overview is to identify all relevant systematic reviews
evaluating upper extremity outcome measures in people
with stroke and provide a synthesis of evidence regarding




A systematic search of the literature was performed in-
dependently by two investigators using electronic data-
bases of PubMed, CINHAL, Cochrane Library, Pedro,
NICE (National Institute for Clinical Effectiveness,
includes MEDLINE, EMBASE and CINHAL). The initial
search strategy was constructed for PubMed and
adapted to other databases. A combination of MeSH
terms and key words entered at three levels was used:
(stroke OR hemiparesis OR hemiplegia*) AND (“upper
extremity” OR “upper limb” OR arm) AND ("outcome
assessment" OR “outcome measure” OR outcome* OR
measure* OR instrument* OR scale* OR test* OR ques-
tionnaire*). To narrow the search following search limi-
tations were used: systematic review, review, abstract
available, publication date from 2004/01/01 to 2014/02/
20, humans, English language, adult: 19+ years, field:
title and abstract. In addition, the lists of related articles
of the included records from the Pubmed search were
screened.
Identification of relevant articles including initial
screening of titles and abstracts, selection of relevant ar-
ticles for the full-text screening and final inclusion were
all performed independently by two authors. Inclusion
of articles was based on the agreement between the two
independent reviewers. When the decision on inclusion
was not clear on the basis of the title or abstract, studies
were selected for further full text screening. The refer-
ences of the articles included for the full text screening
were also hand searched for additional identification of
relevant records, by one investigator and this list was
checked by the second investigator. A flow chart of the
inclusion process is displayed in Figure 1.
Inclusion criteria for reviews:
 systematic reviews published in peer-reviewed
journals,
 involving participants with stroke and/or
hemiparesis due to stroke,
 reporting a clear objective to identify outcome
measures specific for the upper extremity and/or
include measures with a specific separate subsection
for the upper extremity,
Figure 1 Flowchart over the search strategy and article selection process (according to the PRISMA guidelines).
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properties of the outcome measures,
 participants older than 18 years,
 publication year 2004 or later (up to February 2014)
Exclusion criteria for reviews: reviews investigating ef-
fectiveness of interventions or treatments, monitoring
recovery, focusing on diagnostic screening or prognosis,
educational or state-of-the-art reviews, clinical commen-
taries, case reports, non-structured reviews, descriptive
reviews, qualitative reviews, non-human studies. The
grey literature (thesis, reports, conference proceedings,
government documents, policy documents etc.) was not
included. This overview aimed to identify reviews that
intended to include all available instruments for measur-
ing a particular construct (upper extremity functioning)
and therefore, reviews including a single specific instru-
ment or a selection of most common or frequently used
instruments were excluded. The PRISMA guidelines
have been followed when applicable (www.prisma-state-
ment.org). No prior protocol has been published for this
overview and no financial support was sought or re-
ceived for the data analysis or drafting of this manu-
script. Ethical approval was not applicable.Quality assessment and data extraction
The critical appraisal and data extraction of the included
systematic reviews comprised: (1) methodological quality
assessment of the review process, (2) extraction of de-
scriptive information, (3) extraction of upper extremity
outcome measures included in the reviews, (4) identifi-
cation of OM meeting the standards and criteria for psy-
chometric properties as described by the authors of the
reviews, (5) extraction and integration of information onpsychometric properties and clinical utility for the final
set of outcome measures.
There is no specific assessment tool or checklist avail-
able for appraisal of methodological quality of systematic
reviews examining clinical outcome measures and their
measurement properties. In this overview the AMSTAR
(Assessment of Multiple Systematic Reviews) quality as-
sessment tool including 11 items was used as primary
guideline for this process [26,28,29]. AMSTAR contains
items on the quality of search strategy, article selection,
data extraction, appraisal of the scientific quality of the
included studies and how the findings and conclusions
are reported. All included reviews were screened by two
investigators independently using the AMSTAR tool.
Disagreements related to the quality assessment were re-
solved through discussion and, if required, a third re-
viewer was consulted.
Two investigators independently extracted descriptive
data from the included reviews including the publication
years, primary objective, research questions, target popu-
lation, outcome measures (OM), standards and/or cri-
teria used for evaluation of measurement properties of
outcome measures. Firstly, all OM included in the re-
views targeting upper extremity function after stroke
were extracted. Secondly, the OM meeting the criteria
or standards for the psychometrics were identified (pro-
vided by the authors of the reviews). Standards refer to a
defined guideline or clear definition on study design and
methods used for evaluation of the measurement proper-
ties in the primary studies. Criteria indicate a pre-set cut-
off or level that is considered to indicate adequacy for a
good measurement property. If no clear standard was re-
ported in the review, the minimum criteria for psychomet-
rics were set to: at least adequate reliability and validity as
well as reported evaluation of responsiveness or amount
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that met these criteria composed the final set of mea-
sures from which information on psychometric proper-
ties and clinical utility, as reported in the reviews, was
summarized. The clinical utility included two aspects:
time to administer and administration burden (admin-
istration, scoring, interpretation and cost). The data
extraction was performed independently by two investi-
gators and the information was compared. Discrepan-
cies were resolved through discussion and a third
person consulted if required.
Results
Description of included reviews
The literature search process yielded 623 records of
which 13 met the inclusion criteria of this overview on
systematic reviews (Table 1). The search process and
reasons of exclusion of the full text articles are provided
in the Figure 1 (for reasons of exclusion for each full text
article see Additional file 1). Nine of the included reviews
targeted individuals with stroke, and four incorporated
stroke condition as part of a wider population search
(neurologic conditions, adults in community rehabilita-
tion, individuals with spasticity or upper extremity im-
pairments stroke). All reviews used the International
Classification of Functioning, Disability and Health
(ICF) as a framework for classifying the outcome mea-
sures under different domains. Four reviews incorpor-
ate measures at all levels of ICF, one review included
measures at impairment level, four at the activity level
and 3 on both; and one review searched for measures
at the participation level of the ICF alone. Some reviews
had a distinct search area including only measures, for
example, reflecting the “real-life” function, or used in
studies evaluating training with robotic devices [14,21]
or accelerometry [30]. One review incorporated the de-
velopment of clinical practice guidelines for physiother-
apy and one review had the clinical utility as important
criteria. More detailed information on description of
the included reviews is displayed in Tables 1 and 2.
Assessment of the methodological quality
Table 1 summarizes the methodological quality of the
reviews and requirements of the psychometric properties
for the OM as reported by the authors of the reviews.
All reviews presented a clear aim and stated specific in-
clusion and exclusion criteria for identifying the articles
and outcome measures for inclusion and data extraction,
but no review referred to a published protocol regarding
the “a priori” design. The majority of the reviews re-
ported duplicate study selection and half of them also
employed duplicate data extraction process. Four re-
views demonstrated a comprehensive and systematic lit-
erature search and data extraction along with clearlydefined standards and criteria requirements on measure-
ment properties of the outcome measures [14,22,31,37].
Two reviews defined a limitation of sample size (>10) in
inclusion criteria [35,38]. Eleven reviews discussed pos-
sible limitations concerning the publication bias, but
only six reviews provided a clear conflict of interest
statement. All reviews reported the number of included
articles, but only two provided a full list of included
studies [14,30]. All reviews listed and reported the num-
ber of included outcome measures, and six provided ref-
erences or a list of the excluded measures [22,32,
33,36-38]. Five reviews provided information on sample
sizes [14,30-32,38] of the primary studies and three on
the stage of stroke recovery when measurements were
performed [14,30,31]. Although, the quality of the litera-
ture search and evaluation of psychometrics was gener-
ally high in the reviews, the methodology of the primary
studies reporting these psychometric properties was not
assessed using standardized checklists. This resulted in
low total AMSTAR scores, ranging from 1 to 4 for all re-
views (for exact scores, see Additional file 2).
Extracted outcome measures
In total, 53 different upper extremity related OM were
included in the reviews, 31 were included in at least two
reviews and eight in five or more studies (Table 2,
Figure 2). Eight reviews provided sufficient information
of the OM regarding psychometric properties (Table 2).
From those eight reviews, 13 OM were identified that
met the standards and criteria set for the psychometric
properties by the authors of the reviews. The extracted
information on psychometric properties and clinical util-
ity as reported in the reviews is summarized in Tables 3
and 4. This final set of OM comprised five measures pri-
marily targeting impairments of body functions and
eight assessing limitations of activities. These OM cover
a variety of OM assessing gross and fine motor function,
muscle strength, objective movement analysis, dexterity,
functional daily activities as well as self-reported arm
and hand function. The detailed information on stan-
dards and criteria used in the reviews are summarized in
Table 5.
Among the final five OM targeting the impairments of
body functions, the Fugl-Meyer Assessment (FMA,
motor part) demonstrated the strongest level of psycho-
metrics and clinical utility. For Motoricity Index (MI)
the psychometrics are adequate except for responsive-
ness and for Chedoke-McMaster Stroke Assessment
(CMSA) information is lacking concerning the respon-
siveness and the clinical utility is low. The stroke Re-
habilitation Assessment of Movement (STREAM) and
kinematic measures both demonstrated adequate psy-
chometrics, but were only included and evaluated in one
review, thus the information is still limited. Among the
Table 1 Methodological quality assessment of the included systematic reviews
Author year Primary objective or research question Literature search and data extraction process Requirements of the measurement
properties for the outcome
measures in primary studies
Comprehensive search
(>2 databases, strategy)/














Ashford 2008 [22] Identify valid and reliable OM
(real-life function)
Yes/84 Yes Yes Yes Yes Level Standard
& criteria
Baker 2011 [21] Selection strategy and identification
of scientifically sound UE OM suitable
for robot trials
Yes/230 Yes - - Yes Partly Standard
Connell 2012 [31] Review psychometrics and clinical
utility of UE OM
Yes/NR Yes Yes Yes Yes Yes Standard
& criteria
Croarkin 2004 [32] Review and evaluate psychometrics
of UE motor function tests
Yes/170 Yes Yes - Yes Yes Standard
& criteria
Gebruers 2010 [30] Assess psychometrics and clinical
applicability of accelerometry
measures
Yes/25 Yes Yes - Yes yes No
Hillier 2010 [23] Develop and evaluate a process of
OM selection for community settings
Yes/300 Yes - 20% No No Standard
Lemmens 2012 [33] Identify, evaluate, categorize valid and
reliable activity level UE OM
Yes/747 Yes Yes - Yes No No
Platz 2005 [34] Review evidence of psychometric
properties of OM for spasticity
Yes/110 Yes Yes Yes Yes Partly No
Simpson 2013 [35] Review the responsiveness of OM
for UE recovery
Yes/68 Yes - - Yes Yes No
Sivan 2011 [14] Classify, evaluate UE OM used in
robot-assisted trials
Yes/28 Yes Yes Yes Yes Level Standard
& criteria
Tse 2013 [36] Identify, evaluate the psychometrics
of participation OM
Yes/119 Yes - - Yes Yes Standard
& criteria
Van Peppen 2007 [37] Develop clinical practice guideline for physiotherapy
(OM, intervention, prognosis)
Yes/32 Yes Yes Yes Yes Yes Standard
& criteria
Velstra 2011 [38] Review reliability, responsiveness and
content validity of UE OM
Yes/44 Yes Yes - Yes No Not
reported















Table 2 Overview of the measurement level, target population, upper extremity outcome measures included in the re iews and recommended or meeting the
criteria of psychometrics as reported in the primary reviews







List of included OM for UE Recommen ed or met the criteria of psychometrics
Number M Standard or criteria used




6 MAL (12,14, 26, 28 items), ABILHAND,
Leeds Adult Spasticity Impact Scale
1 BILHAND Met 9 of 11 criteria
Baker 2011 [21] Body function
and activity
(robot-assisted trials)
stroke 25 ARAT, CAHAI, 10s test, AMAT, WMFT,
FMA, MSS, MAS, DeSouza, RMA, STREAM,
MESUPE, MI, NHPT, FAT, Sodring Motor
Evaluation Test, Sollerman, MCA, MMAC,













Connell 2012 [31] Body function
and activity (clinical utility)
neurologic
conditions
11 BBT, NHPT, ARAT, ABILHAND, MAL (14,26),
RMA, MSS, Sollerman, Simplified STREAM,
Fitts Reaching test
2 BT, ARAT Clinical utility criteria of ≥8;
criteria of validity, intra/inter-
rater reliability, ability to
detect change
Croarkin 2004 [32] Body function and
functional limitation (no
disability scales)
stroke 9 ARAT, CMSA, FMA, MMAC, MAS, MCA, MI,
NHPT, RMA
6 HPT, FMA, MI,
MSA, ARAT, MAS
Met 2 of 3 criteria: validity,
inter-rater, test-retest reliability;
psychometrics provided
Gebruers 2010 [30]* Activity (accelerometry) stroke NA Accelerometry NA A No specific criteria;
psychometrics provided
Hillier 2010 [23] ICF (clinical use) stroke 7 Manual muscle testing, Tardieu Scale, WMFT,
Grip strength, CAHAI, Hand Active Sensation
Test, NHPT





Lemmens 2012 [33]* Activity stroke, CP 17 AMAT, CAHAI, FAT, TEMPA, ARAT, JHFT, MESUPE,
WMFT, ABILHAND, MAL, DHI, UBDS, Actual











Platz 2005 [34]* Body function (spasticity) stroke, MS, SCI
and CP with
spasticity
11 Ashworth Scale (original, modified, velocity
corrected), Muscle Tone Scale, Modified
Tardieu Scale, VAS for tone, Tone assessment
Scale, ROM (goniometer, estimation), Finger
curl test, Tendon reflex scale
0 No specific criteria;
psychometrics
not provided
Simpson 2013 [35]* Activity (responsiveness) stroke 14 ABILHAND, AMAT, ARAT, Accelerometry, CAHAI,
DHI, FAT, Functional Test, Hand Function Survey,
JHFT, MAL, SIS, TEMPA, WMFT
5 BILHAND, ARAT,
AL, SIS, WMFT
No specific criteria; MCID
values provided
Sivan 2011 [14] ICF (robot-assisted trials) Stroke 17 FMA, MSS, CMSA, Ashworth Scale, MRC,
Kinematics, Grip strength, NHPT, BBT, ARAT,















































Table 2 Overview of the measurement level, target population, upper extremity outcome measures included in the reviews and recommended or meeting the
criteria of psychometrics as reported in the primary reviews (Continued)
Criteria for reliability, internal
consistency, validity
van Peppen 2007 [37] ICF (clinical utility for
physiotherapy practice)
stroke 10 Core set: MI, FAT; Optional: ROM, Numeric Pain
Rating Scale, Nottingham Sensory Assessment,
Modified Ashworth Scale, FMA, Hand volumeter,
ARAT, NHPT
2 MI, FAT (core set) Level of evidence at least 2
(psychometric properties,
clinical utility, ICF)







8 Ashworth Scale, ARAT, MAL, WMFT, JHFT, FMA,
Muscle strength, ROM
2 ARAT, MAL No specific criteria; grading




*Reviews did not provide standards, criteria or sufficient information on psychometrics needed for qualification; OM printed in italic were included into the final set (n = 13); Abbreviations: ICF International Classification
of Functioning, Disability and Health, OM outcome measures, UE upper extremity, MS Multiple sclerosis, SCI spinal cord injury, CP cerebral palsy, CAHAI Chedoke Arm Hand Activity Inventory, STREAM Stroke
Rehabilitation, Assessment Movement, BBT Box and Block Test, ARAT Action Research Arm Test, NHPT Nine Hole Peg Test, FMA Fugl-Meyer Assessment (motor), MI Motoricity Index, CMSA Chedoke-McMaster Stroke
















Figure 2 Overview of outcome measures (OM) included in the reviews more than once (gray bars) and the number of times the OM
met the criteria set for psychometric properties as reported in the reviews (black bars).
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level of psychometrics and clinical utility has been estab-
lished for four capacity measures: Action Research Arm
Test (ARAT), Box and Block Test (BBT), Chedoke Arm
and Hand Activity Inventory (CAHAI), Wolf Motor
Function Test (WMFT) and for a measure assessing per-
ceived performance, ABILHAND. Responsiveness was
low or information not provided for Frenchay Arm Test
(FAT), Motor Assessment Scale (MAS) and Nine Hole
Peg Test (NHPT). Thus, in total, six outcome measures
(FMA, ARAT, BBT, CAHAI, WMFT and ABILHAND)demonstrated high level of measurement quality and
clinical utility and can therefore be recommended for
evaluation of upper extremity function and activity after
stroke.
Figure 3 provides an overview of the publication years
of the primary references used in the systematic re-
views. Figure 4 illustrates the overlap of the primary ar-
ticles included in the reviews, which was in average
19%. Accordingly, for nine OM none or only one pri-
mary source was used in more than one review, for
BBT and ABILHAND 2 out of 6 primary articles were
Table 3 Summary of psychometric properties and clinical utility of the outcome measures of impaired body function
that met the standards or criteria set for the psychometric properties by the authors of the reviews
FMA MI-arm CMSA STREAM Kinematics
References [32] [14,38] [32,37] [32] [14] [21] [14]
Psychometric properties
Content validity + NA
Internal consistency *** + NA
Construct validity + *** *** + **
Concurrent validity + *** + + +
Floor/ceiling effect ** NR NR
Intra-rater, test-retest reliability + *** + NR + ***
Inter-rater reliability + *** + + *** +
Responsiveness ** * NR ***
MCID, points 7p NR NR
MDC/SDD, points 12p
Clinical utility
Time to administer, minutes 20 10-15 60 varies
Administration burden ** * **
+Met the criteria set by the authors of the reviews (not graded); ***High/excellent/very good; **Moderate/good/adequate; *Low/poor; Administration burden
includes: administration, scoring, interpretation and cost. Abbreviations: NR Not reported, NA Not applicable, p points, s seconds, MCID Minimal clinically important
difference, MDC Minimal detectable change, SDD smallest detectable difference, empty space: not covered by the reviews; FMA Fugl-Meyer Assessment (motor),
MI Motoricity Index, CMSA Chedoke-McMaster Stroke Assessment, STREAM Stroke Rehabilitation, Assessment Movement, FMA demonstrated a high level of
measurement quality and clinical utility.
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for ARAT 7 of 19 references were used in more than
one review.
Discussion
The aim of this overview was to summarize and
synthesize findings from single systematic reviews identi-
fying the upper extremity outcome measures and evalu-
ating the psychometric properties of these measures for
stroke population. This approach enables a broader view
of the research area and makes integration of findings
possible between reviews using slightly different objec-
tives or methodological process. In addition, unified
findings from several reviews can provide a larger body
of evidence and strengthen the recommendations based
on these findings. In addition, areas were the evidence is
lacking can be clarified and targeted in the future stud-
ies. To our knowledge, this overview is the first paper
where the findings from multiple systematic reviews on
upper extremity outcome measures has been summa-
rized and integrated in a standardized way.
Several investigators have pointed out the importance
of using clear and unified criteria for evaluation of the
psychometric properties [16,21,39]. In the current over-
view, 8 of 13 reviews provided sufficient information re-
garding the psychometrics so that the OM meeting the
criteria for psychometrics could be identified. Even when
some variation between studies concerning the require-
ments set for the psychometrics could be observed, the
differences were relatively small. In this overview, thepsychometrics from different studies were integrated
and the criteria used by the authors of the reviews are
provided. This transparent reporting enables reasonable
comparison between the findings from the reviews and
also highlights the gaps in the research area.
In this overview of systematic reviews, 13 outcome
measures met the standards and criteria set for the psy-
chometric properties. Six of those, Fugl-Meyer Assess-
ment (FMA), Action Research Arm Test (ARAT), Box
and Block Test (BBT), Chedoke Arm and Hand Activity
Inventory (CAHAI), Wolf Motor Function Test
(WMFT) and ABILHAND, demonstrated a high level
of measurement quality and clinical utility when infor-
mation provided in the systematic reviews of psycho-
metrics and clinical usefulness was taken into account.
The psychometric properties of these six OM have been
evaluated thoroughly in several studies. These OM are
also widely used in research and in clinical practice and
can be considered to have an acceptable and compar-
able clinical usability (administration, scoring, inter-
pretation, cost and portability). Based on the findings of
this overview, each of these six OM can be recom-
mended to use for upper extremity assessment after
stroke. However, when selecting a measure; the specific
requirements of the study or clinical treatment goal,
the expected outcome, the upper extremity disability
level and the setting where the OM will be used, will
need to be taken account. In addition, if several aspects
of functioning are to be targeted, there is a need to in-
clude OM at different ICF levels [40,41].
Table 4 Summary of psychometric properties and clinical utility of the outcome measures of activity limitation that
met the standards or criteria set for the psychometric properties by the authors of the reviews
BBT ARAT CAHAI WMFT ABILHAND FAT MAS NHPT
References [31] [14] [31,32] [14,35,38] [21,23] [14] [14,38,35] [21,22] [14,35] [37] [14] [32] [14] [32] [14]
Psychometric properties
Content validity + + NA
Internal consistency *** + *** + NA
Construct validity *** + ** + *** *** + ** NR + *** + ***
Concurrent validity + + + *** + + + +
Floor/ceiling effect NR * NR * * * NR NR
Intra-rater/test-retest
reliability
+ *** + *** + NR *** + + *** *** +
Inter-rater reliability + *** + *** + *** *** + *** *** + *** + ***
Responsiveness NR ** + *** ** + ** * NR NR
MCID, points, seconds 6
blocks













Administration burden *** ** ** ** ** *** ** ***
+Met the criteria set by the authors of the reviews (not graded); ***high/excellent/very good; **moderate/good/adequate; *low/poor; aequal to effect size 0.2,
bclinical scale anchor, cglobal rating, dpercentage of recovery (Simpson [35]); empty space, not covered by the reviews; Administration burden includes:
administration, scoring, interpretation and cost. Abbreviations: NA Not applicable, NR not reported, MCID minimal clinically important difference, MDC minimal
detectable change, SDD smallest detectable difference, SRD smallest real difference, BBT Box and Block Test, ARAT Action Research Arm Test, CAHAI Chedoke Arm
Hand Activity Inventory, WMFT Wolf Motor Function Test, FAT Frenchay Arm Test, MAS Motor Assessment Scale, NHPT Nine Hole Peg Test, BBT, ARAT, CAHAI,
WMFT, ABILHAND demonstrated a high level of measurement quality and clinical utility.
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tions made for OM in existing guidelines. All six recom-
mended OM, apart from the CAHAI and ABILHAND,
have also been recommended by the Dutch Clinical
Practice Guideline for physical therapy in patients with
stroke [12] or by the Neurology section of the American
Physical Therapy Association (StrokeEdge task force)
[13]. Both, CAHAI and ABILHAND are relatively new
OM and this can be one possible reason why these have
not yet been included in the guidelines. However, for
two OM, the Frenchay Arm Test and the Motoricity
Index, which both are recommended as basic OM in
Dutch guidelines, the evidence reflected in the reviews
regarding the responsiveness was not sufficient. As it
can also be observed from Figure 3 in this overview,
there is a clear lack of later studies, which can explain
the poor reporting of responsiveness for these two OM.
Nevertheless, the responsiveness is an important meas-
urement property which needs to be considered when
OM are selected for evaluation of treatment effects in
clinical trials.
Findings from the current overview demonstrate that,
at the body function level, the FMA was the only OM
with sufficient evidence regarding the psychometric
properties. This result suggests that the use of FMA
(motor part) is warranted in research and in clinicalpractice. However, there is a need to improve and evalu-
ate further other commonly used measures of motor
function along with measures that evaluate other aspects
of impairment, such as strength and range of motion.
On the activity level, five capacity measures could be
recommended. Among those, the BBT can be classified
as fast screening tool for gross manual dexterity, provid-
ing information about the speed of performance, but
offer no information on the reason of impaired perform-
ance or the quality of movement. The other three rec-
ommended capacity measures (ARAT, CAHAI, WMFT)
are more time consuming and rely on the expertise of a
therapist when the movement performance is scored. In
general, these activity capacity measures assess the abil-
ity to perform functional tasks including lifting and
moving of objects of various shapes and sizes. There is
however some differences between these scales, e.g. in the
ARAT the affected arm is assessed unilaterally, in the
WMFT two bimanual items are tested, while in the
CAHAI only bimanual tasks are assessed; in the WMFT
the tasks are both timed (WMFT-time) and scored (func-
tional ability score), while in the ARAT the time compo-
nent is integrated into the different scoring levels; both in
ARAT and WMFT the maximum score cannot be reached
when compensatory movements are used for task comple-
tion in contrast to CAHAI where the independence and
Table 5 Standards and criteria for psychometrics and clinical utility provided by the authors of the reviews
Review Criteria of psychometrics or clinical utility provided by the authors of the reviews
Ashford [22] Content validity, internal consistency, construct validity, test-retest reliability, agreement, responsiveness, interpretability:
adequate design, method and results (Chronbach’s α: adequate 0.7-0.9, ICC: > 0.70); minimal clinically important difference
presented, floor/ceiling effect≤ 15%, time to administer < 10 min, administration burden: easy to sum up the items
Baker [21] Psychometric testing have been performed
Connell [31] Clinical utility criteria of≥ 8points (time to administer and interpret≤ 30 min, cost≤₤ 100, simple equipment, portability),
reliability/validity (kappa, correlation coefficients, ICC/r: strong≥ 0.80, moderate 0.6-0.8, weak 0.4-0.6), ability to detect change
(measurement error, standardized response mean, standardized error of measurement, limits of agreement, minimal
detectable change)
Croarkin [32] Significant correlations (p < 0.05) for test-retest, inter-rater reliability and validity (convergent, concurrent): level of evidence
1 =meets all 3 psychometrics criteria, level 2 =meets 2 of 3 criteria
Hillier [23] Sound psychometrics: content and construct validity, reliability, sensitivity to change, utility (interpretability,
acceptability, relevance)
Simpson [35] MCID values calculated (related to effect size 0.2, anchor-based method using clinical scale, global rating,
percentage of recovery)
Sivan [14] Test-retest reliability (ICC/kappa: high/excellent≥ 0.75, moderate 0.40-0.74, poor <0.40); internal consistency
(Chronbach’s α: high/excellent > 0.80, adequate 0.70-0.79, low < 0.70); validity (correlation coefficient: excellent
r > 0.60, adequate 0.30-0.59, poor <0.30), area under the curve: excellent > 0.90, adequate 0.70-0.89, poor < 0.70);
responsiveness (effect size: large > 0.8, moderate 0.5-0.79, small <0.50; other adequate responsiveness methods,
MCID value); floor/ceiling effect (excellent 0%, adequate < 20%, poor > 20%), respondent burden: (time, acceptance:
excellent < 15 min, adequate: longer time, lower acceptability; poor: lengthy, acceptability problem); administrative
burden (excellent: scoring by hand, easy to interpret, adequate: computer scoring, obscure interpretation; poor:
costly, complex scoring/interpretation)
Tse [36] Inter-rater, test-retest reliability (kappa/r/ICC > 0.75), internal consistency (Chronbach’s α > 0.80), content
validity, construct validity (adequate method, r ≥ 0.60)
van Peppen [37] Valid for stroke, test-retest reliability and concurrent validity (ICC/r ≥ 0.70), responsiveness (high/low),
time to administer≤ 15 min, test-protocol available: level of evidence 1 =meets all 6 criteria, level 2 = meets
5 of 6 criteria
Velstra [38] Reliability (correlation coefficient, kappa, Chronbach’s α, ICC): very good or good/moderate; Responsiveness
(effect size, standardized response mean): moderate or large
Abbreviations: ICC Intraclass coefficient, MCID minimal clinically important difference.
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In addition to capacity measures, the ABILHAND can
also be recommended to capture a person’s self-perceived
manual performance during common daily life activities.
One advantage using the ABILHAND is that it is validated
using Rasch analysis method, which means that the score is
expressed in logits and can be considered as an interval lin-
ear measure in statistical calculations [42]. It is however im-
portant to consider the implications of cognitive functions,
such as memory and language deficits, which can signifi-
cantly influence the validity of final score. Likewise, the
ABILHAND questionnaire is most suitable in subacute and
chronic phases of the stroke, when the person with stroke
has some experience of performance difficulties during
daily activities, so that these may be reliably scored.
In this overview, only reviews using systematic litera-
ture search were included in order to enable an unbiased
selection of the outcome measures. There are, however,
several publications available where detailed description
on measurement properties for most common outcome
measures is provided. Extensive work has been pre-
sented by the American Physical Therapy Association
Neurology section task force, in which recommendationson OM were made for clinical practice, research and
education. Four outcome measures, ARAT, BBT, FMA
and WMFT recommended in this systematic overview
were also recommended by this task force for use
throughout different practice settings and during differ-
ent stages of stroke recovery [13]. Another comprehen-
sive overview of the psychometric and administrative
properties of most common OM in stroke rehabilitation
has also been provided by the Salter et al. [16,39]. Simi-
lar to our findings, it was concluded that reporting of
the reliability and validity was relatively consistent across
the scales, but less information was available on the re-
sponsiveness [16,39].
The majority of the OM extracted into the final list
are well-established observational clinical scales using
ordinal scoring. Even though the good psychometric
properties have been demonstrated for these scales, the
ordinal scoring is considered to be less sensitive to
change compared to continuous scales and highly
dependent on the observer and the pre-set scoring
levels. The disadvantage of both observational scales and
timed testing such as NHPT, BBT is that the qualitative
detailed information of movement performance and
Figure 3 Publication years for the primary references used in the systematic reviews and years when the reviews were performed,
presented separately for every outcome measure included into the final set of measures.
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[43]. To capture these movement qualities a more so-
phisticated, detailed and potentially technological assess-
ments are often required. Kinematic movement analysis,
which also was identified in one of the reviews, is one
such method that allows a more detailed analysis of
movements. Today, the most established method for
kinematic analysis is the optoelectronic motion capture
systems. However, considering the cost, availability, and
knowledge needed for this kind of movement analysis,
the main application area will predominantly remain to
be in the research.
The current rapid development of technologies, such
as inertial sensors, providing kinematic data on upperFigure 4 Total number of references used in the reviews and number o
presented for outcome measures included into the final set.extremity use in daily life both inside and outside the
laboratory is exciting. There is opportunity to extend
the quality and accuracy of measurement, filling the
gaps not covered by the more traditional clinical scales.
However, there are variations between the different
technology-assisted systems and no standardized guide-
lines or test procedures have been established. This was
also observed in this overview, where two reviews in-
corporated accelerometer-based assessments, with no
standardized evaluation on psychometric properties
provided by the authors of the reviews. The instru-
mented testing, where the performance during a clin-
ical assessment is complemented with simultaneous
acquisition of movement data gathered from motionf references that were only used in one review (unique references)
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jects, is another promising method that provides a
more objective clinical assessment [44-47]. For the pa-
tient reported measures, the computerized adapted
testing is also emerging and would considerably de-
crease the patient and administrator burden for infor-
mation collection [48,49]. More research is, however,
needed regarding the benefits of these instrumented as-
sessment tools and their psychometric properties.
Limitations and strengths
Our approach to integrate findings from multiple re-
views has some limitations. First, the conclusions are
based on the information provided by the authors of the
reviews and data from primary studies was not retrieved
or evaluated. Second, it could be expected that there
would be some overlap of primary articles used for
reporting the psychometric properties of outcome mea-
sures in the reviews. This overlap was, however, small
(<20%) in the current systematic overview. For the ma-
jority of outcome measures none or only one primary
source was used in more than one review. A larger over-
lap was only observed for two OM (ARAT, FMA) in
which also the number of original articles was larger.
In the current overview the reviews older than ten
years were not included. This decision was based on the
argument that there has been a shift of paradigm regard-
ing the evaluation of the psychometric properties of the
measurement scales. The requirements on appropriate
statistical methods and interpretation of the results have
been changed compared to earlier studies. The intention
was to capture information of up-to-date measurement
scales. It is also evident that recently developed newer
OM, including technology-assisted OM, have not been
included in the reviews and are subsequently not captured
in the current overview. Findings from this overview
showed also that the methodological quality of the in-
cluded systematic reviews was relatively high regarding the
literature search and the study selection, but limited infor-
mation was provided concerning the primary studies where
the outcome measures were extracted from. To improve
critical appraisal of the methodological quality in primary
studies, validated checklists and standards should be used
in the future reviews. One such checklist has been devel-
oped for the health-related patient-reported outcomes
(COSMIN-checklist), which can give some guidance also
for evaluation of other measurement instruments, such as
clinical rating scales [50].
Conclusions
This overview of systematic reviews provides a compre-
hensive systematic synthesis of evidence regarding the
psychometric properties and clinical utility of the upper
extremity outcome measures after stroke. The findingsfrom this overview can provide guidance for clinicians, re-
searchers and policy makers for evidence-based outcome
measure selection. Altogether, thirteen outcome measures
met the standards and criteria set for the psychometric
properties and six of those demonstrated a high level of
measurement quality and clinical utility. The Fugl-Meyer
Assessment (FMA) on body function level and the Action
Research Arm Test (ARAT), Box and Block Test (BBT),
Chedoke Arm and Hand Activity Inventory (CAHAI), Wolf
Motor Function Test (WMFT) and ABILHAND on activity
level cover a broad spectrum of assessments and can be
recommended for assessment of upper extremity function
and activity in research and clinical praxis. Future research
needs to investigate the psychometric properties of other
commonly used OM on body function level and the up-
coming technology-supported upper extremity measures.Additional files
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